CSL 1.51% $306.60 csl limited

CSL possible pull back to low $200's, page-161

  1. 5,952 Posts.
    lightbulb Created with Sketch. 281

    A spokesperson for Health Minister Greg Hunt said the Government's decisions were "being driven by the combination of scientific advice from medical experts" on the advisory body chaired by former Chief Medical Officer Professor Brendan Murphy.

    "The AstraZeneca/Oxford vaccine clinical trials demonstrated the vaccine is generally well tolerated and effective at preventing symptomatic COVID-19 and that it protects against severe disease and hospitalisation," the spokesperson said.

    "The TGA is currently evaluating the safety, quality and efficacy of the AstraZeneca/Oxford vaccine under its provisional approval pathway.

    "A decision to provisionally approve the vaccine will be made following rigorous assessment of all the available data.
    https://www.abc.net.au/news/2021-01-13/government-coronavirus-vaccine-rollout-astrazeneca-efficacy/13053302

    "Further detail on vaccine efficacy is being collated now and includes data from many millions of vaccinations across countries that have used early authorisations, such as the US, Canada and the UK."

 
watchlist Created with Sketch. Add CSL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.